Rybelsus (semaglutide) is a prescription GLP-1 oral medication used along with diet and exercise to improve blood sugar in adults with type 2 diabetes.
Rybelsus (semaglutide) is a prescription medicine manufactured by Novo Nordisk, used to improve glycemic control in adults with type 2 diabetes. As the first oral GLP-1 receptor agonist pill, it is designed to be taken once daily.
Our directory provides comprehensive prescribing information, medication guides, and patient instructions for the safe dosage and administration of Rybelsus. Always consult your healthcare provider regarding your medical treatment plan and refer to the official medication guidelines for safety warnings.
Selected manuals from manuals+ curated for this brand.
Common questions about manuals, registration, and support for this brand.
Rybelsus is a prescription medicine GLP-1 pill used along with diet and exercise to improve blood sugar in adults with type 2 diabetes.
Take Rybelsus at least 30 minutes before the first food, beverage, or other oral medications of the day with no more than 4 ounces of plain water only. Waiting less than 30 minutes, or taking with food or other beverages will lessen the effect of the medication.
No. You must swallow the tablets whole. Do not split, crush, or chew the tablets.
If a dose is missed, the missed dose should be skipped, and the next dose should be taken the following day. Do not take two doses at once.